Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It reminds me of Kenny boys last skiing vacation.
Down down downhill!
Quote:
"I enjoy PMCB chart posting it show the years on downward movement and how wrong they are"
It does get old but I find reading some of these ridiculous theories brings me back to being a kid, laughing at the comics in the newspaper.
I do applaud your efforts to get some transparency I just think it will be in vain.
Good luck;)
This should be interesting. I'll be surprised, actually shocked if any amounts that were not on the latest 10k are given in a private email.
I'm looking forward to all the >real< email responses and or excuses made for or by pmcb for the lack of.
Good luck!
Pmcb big pharma nda lmao
Dr. Günzburg and Dr. Salmons are involved in numerous aspects scientific endeavors relating to our cancer and diabetes therapies, having initially commenced work for us as consultants at the beginning of 2014 under an oral agreement. They provide services to us as consultants through their consulting company, Vin-de-Bona Trading Company Pte Ltd (“Vin-de-Bona”). This arrangement was formalized in writing as of April 1, 2014, when we entered a Consulting Agreement with Vin-de-Bona. The Consulting Agreement has an initial term of 12 months, with additional terms of 12 months automatically renewing unless either party terminates an additional term upon 30 days’ prior written notice. The professional services rendered to us by Dr. Günzburg and Dr. Salmons are charged at a negotiated and confidential hourly rate.
The Consulting Agreement requires that Dr. Günzburg and Dr. Salmons not disclose or use our confidential information for any purpose, other than performing services under the Consulting Agreement, without our prior written consent. In addition, during the term of the Consulting Agreement and for a period of twelve months after termination or expiration of the Consulting Agreement, Dr. Günzburg and Dr. Salmons are prohibited from soliciting any of our customers, employees, suppliers or other persons with whom they had dealings during the tenure of their consultancy with us.
pmcb stated this but won't help when SEC comes BACK knocking:
"Our relationships with customers and third-party payors will be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, substantial civil penalties, contractual damages, reputational harm and diminished profits and future earnings."
No they're about to air on American Greed. SEC is coming for pmcb
Buyer Beware!
But but their web page is so professional looking lmao!
CMP
Specializing in:
Literacy
TV&Film packaging
Commercials rights
Event Management
Media Relations
I thought I read somewhere pmcb was a Biotech Company? Now it's confirmed they're getting ready to air on American Greed
http://creativemanagementpartners.com
No?
Quote:
"The sort of people pcmb are attracting do not have time to waste."
How long ago did pmcb beg TD2 and Dr Von Hoff to work with them?? Still not a word after 3 years of any results of studies supposedly done.
Pmcb = Scam of the year
Lmao pmcb crew is selling them as fast as they get them leaving retail holding the bag full of empty dreams of jnj. Proof is in the volume and price.
Looks as though pmcb has been beaten. Notice these guys also are protected with patents.
http://medcraveonline.com/JLRDT/JLRDT-01-00013.php
What does this have to do with pmcb?
Nothing that's what.
http://medcraveonline.com/JLRDT/JLRDT-01-00013.php
APRIL 06, 2016 over a year ago and nothing to do with pmcb. Every article that has anything to do with pancreatic cancer or Diabetes or Biotech buyouts is tried desperately I might add to be connected with pmcb. Why is that? Lack of updates from this scam have minds wandering?
How is tic tac toe relevant to pmcb? Oh I get it there both games.
Bavarian Nordic is laughing their asses off for unloading CIAB to pmcb.
Bullshit the FDA agreed. Clearly states is pmcb pr.; "In PharmaCyte’s recent pre-IND meeting with the FDA, the FDA stated that it would be willing to change PharmaCyte’s clinical trial from an “exploratory” trial to a “pivotal” trial under certain conditions. I find it helps to actually read the pr's regardless if their full of ridiculous claims.
Big differences.
Kite works
PMCB doesn't.
Kite had 89% institutional owners.
PMCB 0.11%
Kite had insiders buying
PMCB had NONE
KITE bought for $11bil
PMCB was passed up for $2mil
KITE is a real Biotech
PMCN is a real SCAM
Quote:
"Gilead buys Kite and its personalized technology for harnessing the body’s immune system to fight cancer for $11B cash."
Bullshit says who?? FDA? Nope didn't think so.
Quote:
CIAB has to be worth at least double or triple, because it can be applied to numerous cancer treatments, let alone diabetes and MMJ treatments.
This blows pmcb so called results out of the water! Now I see why Dr. von hoff has been mia on pmcb's CIAB.
TGen-HonorHealth Research Institute clinical trial reports high rate of tumor shrinkage among patients with advanced pancreatic cancer
SCOTTSDALE, Ariz. - April 25, 2017 - Adding cisplatin to the standard gemcitabine/nab-paclitaxel drug treatment provided a very high rate of tumor shrinkage for patients with advanced pancreatic cancer, according to the results of a pilot clinical trial conducted by the HonorHealth Research Institute and the Translational Genomics Research Institute (TGen).
These statistically significant and clinically meaningful improvements in overall response and survival rates resulted from a phase Ib/II clinical study performed at the HonorHealth Research Institute, a partnership of HonorHealth and TGen.
The results were presented during the 2017 Gastrointestinal Cancers Symposium, sponsored by the American Society of Clinical Oncology, in San Francisco. Connecting a global network of more than 40,000 cancer professionals, the society serves as the leading resource for best practices in clinical oncology research and academic and community practices.
"After just three treatment cycles, we saw tumor markers plummet and some patients' tumors shrink significantly in just nine weeks," said Gayle Jameson, nurse practitioner and principal investigator of the clinical trial, who is highly encouraged by the response. "After treatment, two patients had no evidence of disease and are alive over three years after starting this regimen. This is very rare with traditional chemotherapy."
Dr. Daniel Von Hoff, TGen Distinguished Professor and Physician-in-Chief who devised the clinical trial, agreed: "Although a small study, the high response rate and landmark evolving median survival are very encouraging, and this regimen is being expanded for patients with stage IV pancreatic cancer." Dr. Von Hoff also is chief scientific officer at the HonorHealth Research Institute.
Of the 24 evaluable patients (those whose response to a treatment could be measured because enough information was collected) who were enrolled in the study:
Eleven patients are still alive. The median overall survival rate of 16.5 months exceeds the historical average survival of six-12 months with standard chemotherapy.
Seventeen of 24 patients - 71 percent - had a reduction in tumor size of at least 30 percent.
Two of those 17 patients had a complete response - no detectable tumor.
This pilot clinical trial began in 2013 through a partnership between the HonorHealth Research Institute and TGen. It was funded by Stand Up To Cancer, Mattress Firm, the Arizona Diamondbacks, and the Scottsdale-based Seena Magowitz Foundation.
Symptoms of pancreatic cancer usually do not appear until the disease progresses to its late stages, making it difficult to treat. Only about one in four patients survives more than a year after diagnosis, and fewer than 10 percent survive more than five years. Pancreatic cancer this year will take the lives of more than 43,000 Americans, making it the nation's third-leading cause of cancer-related death.
The results of this trial are encouraging and deserve additional testing prior to becoming a standard of care for patients with advanced pancreatic cancer. Through research, the HonorHealth Research Institute and TGen aim to provide hope and a better chance for patients to live for years instead of months.
The current standard of care for advanced pancreatic cancer - a combination of nab-paclitaxel and gemcitabine - was developed by TGen and the HonorHealth Research Institute, and approved by the U.S. Food and Drug Administration in 2013.
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. TGen is allied with City of Hope, a world-renowned independent research and cancer and diabetes treatment center. This precision medicine alliance enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. For more information, visit: www.tgen.org.
Pmcb FAIL Ichimoku
Pmcb (cell in a box) concept that's as promising as those free energy devices. There's believers in those but never has one worked and only ones to get rich were those selling the scams.
BELIEVERS pay attention:
FOR THE RECORD:
I predict Kenny boy will step down taking his $ right before news that CIAB has been returned and no ind will be submitted. Leaving true believers devastated, cities everywhere securing roof tops and bridges.
Quote:
"CIAB is a gimmick that every real biotech knows won't work. Its been around for 20 years and has attracted zero interest except for two con artists pat Grudden and Bob Ryan who saw a opportunity 6 years ago to buy the rights because their natural cure company scam had run its course. Then they brought on Kenny esq fresh off his last penny stock scam at chinatel. What did he do almost immediately? Granted the old nuvilex crew $Millions in shares on their way out the door and rewarded himself and Crabtree $Millions for doing nothing. Soon someone new or already associated will take over so Kenny and Crabby can sell their shares and retire very wealthy."
Yup that was a good one as well. Anybody know how many pump pieces SMMG has done for pmcb/nvlx since ciab became (zombie biotech) pmcb new scam?
Quote:
What about the head to head with Eli Lilly! Scam man
You've never seen Kenny boys or crabtrees contract? Raping investors of $ since 2013. Here's a link I had it's been updated to reflect there raises since then.
Kenn Kerr? oh ya I believe that! It's all a scam and some will soon see the truth.
http://www.sec.gov/Archives/edgar/data/1157075/000101968715000953/0001019687-15-000953-index.htm
Yup sounds like the trading expected for a company claiming to cure the world of Pancreatic cancer and T1 Diabetes doesn't it?
People aren't as stupid as Kenny boy hoped to continue to believe the bullshit spewing from his mouth.
Quote:
"$200 in trading so far today..."
Kenny Waggoner sucking investors dry since 2013!
Wow serious speculation. Love the wording as to make this post sound like jnj is partnering with pmcb. If I didn't see the name I would have sworn this bullshit came off of SMMG press.
Quote:
"Janssen Pharmaceuticals will be our partner, imho, and here is why in chronological order:
First the NDA's were signed: http://pharmacyte.com/pharmacyte-seeks-to-solve-pancreas-puzzle-with-cell-in-a-box/ "...
NDA are and have always been with Bravarian Nordic & Austrianova, Bluebird regarding CIAB.
the company also is assessing the interest of big pharmas, and many have signed non-disclosure agreements.
Those I just listed like how pmcb made it sound like it was more than it actually is?? Scam
Followed with a pr regarding Johnson & Johnson:
Pmcb main Pumping analysis stock market media group who have received shares and cash to pump pmcb. That the equivalent of getting facts from CNN
PharmaCyte then hired a former J & J exec:
What better way to pump pmcb than get a guy booted from jnj to make this rumor bigger.
KW then publicly posted on FB, (prior to taking his FB account private), "150 years and still going strong according to my Canadian colleagues. At PharmaCyte, they will soon outnumber the Americans."
Referring to pmcb 4 employees nationalities was again blown out of proportion. KW playing his little investors just like the Pied Piper.
Followed by Bavarian Nordic's recent expansion deal with Janssen:
Who cares? Bavarian Nordic isn't PharmaCyte. Matter of fact BN unloaded their loser product "Cell in a Box" to pmcb!
Bavarian Nordic is the forerunner to Austrianova:
Again who cares? Nothing to do with PMCB
J & J is the parent company of Janssen Pharmaceuticals. J & J has the largest presence in Canada of all pharmaceutical companies:
So what has nothing to do with pmcb
Additionally, and most recently, PharmaCyte appointed Dr. Abecassis to their Board of Directors and Dr. Sher as their Chief Medical Officer.
Dr's join many boards and take passive roles as proven here many times. Collect easy money in exchange for the company to use their name.
Nice! But here's an idea if I wanted to throw money away to pmcb. Just send the money right over to KW's personal bank acct. No broker fees, no worthless stock and could possibly write it off as a donation.
It's all been proven false info on pmcb so it's gone!!
J/k it's false but not gone. Hit the show intro tab top right of page.
That video is nothing but bullshit propaganda pmcb made to sucker people in. Fact
Let's see those 888 or 488 trades to pump pmcb's close price up!! Come on 8er pmcb loves giving false hope!
Why hasn't pmcb kept any promises or progressed CIAB since they acquired the license in 2013??
Why has management quadrupled their salaries for poor performance
and doing nothing for the retail investors
Why have "long" investors been paying for Kenn Waggoner personal vacations and continue to do so.
Wow that chart is looking worse than I thought .05 on deck! Next week perhaps
Snake oil is the only thing pmcb has been trying to sell to investors.
Biotechs are on a terror today!! I'm up 200% on some calls today in one! Real money means investing in real companies. pmcb is not only an epic failed p&d.
Great post!! pmcb only purpose is to plant fantasies into its investors heads, take their money and give themselves raises for the shit job they've done running this scam.
"Hey I know of this great company cheap.
1-They use to be a natural cure company that never made a dime.
2-They decided six years ago to become a biotech.
3-They bought a 20 year old treatment that hasn't been in any trial for 17 years.
4-They hired a shady penny stock lawyer five years ago as CEO and he has paid himself around $15,000,000
5-They hired a washed up old doctor as COO and have paid him over $10,000,000
6-They hired a shady CFO from the same company as the shady CEO and have paid him a couple $Million the past two years.
7-They have spent $Millions on stock promotions claiming that clinical trials will start in 2014,2015,2016 and now 2017
8-They have no physical office or research space.
9-They have no money to pay for trials nor do they have anyone willing to partner with them.
10-Six years after buying this 20 year old treatment thats last trial was 20 years ago they still can't file an Ind."
Buyer Beware!
Must not know to well because pmcb has been pumped in numerous sites throughout the last 3-4 years. Including more popular ones such as Benzinga, The Street, Market Watch and seeking alpha.
No buyers for this pos.